Foundation Medicine

Foundation Medicine, Inc.
Company typeSubsidiary
Nasdaq: FMI
Headquarters,
United States
Key people
Daniel Malarek (CEO)
ProductsFoundationOne CDx FoundationOne Liquid FoundationOne Heme Foundation Insights FoundationSmartTrials
RevenueIncrease $152.9 million (2017)[1]
ParentRoche
Websitefoundationmedicine.com

Foundation Medicine, Inc. is an American company based in Cambridge, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.[2]

  1. ^ "Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook | Foundation Medicine".
  2. ^ Staff (15 January 2015). "Cambridge startup soars on Roche stake". Business. The Boston Globe.